Connect with us

Hi, what are you looking for?

Global Markets ReviewGlobal Markets Review

Tech News

Celeste developers cancel follow-up game Earthblade

A screenshot from Earthblade.
Image: Extremely OK Games

Earthblade, the next game from the developers of Celeste, has been canceled. The fantasy-inspired game got its first trailer in late 2022, and the game would have let you explore a “free-roaming, dynamically-loading map,” Extremely OK Games’ Maddy Thorson said at the time. But the team decided to cancel the game in December after a team conflict and because of the pressure of trying to follow up on Celeste, Thorson says in a post detailing what happened.

The “disagreement” was between Thorson and Noel Berry (Thorson refers to the two of them as “us”) and Pedro Medeiros over “the IP rights of Celeste,” Thorson says. “We eventually reached a resolution, but both parties also agreed in the end that we should go our separate ways,” and Medeiros is currently working on a game called Neverway. “Losing Pedro wasn’t the only factor in cancelling the game, but it did prompt us to take a serious look at whether fighting through to finish Earthblade was the right path forward,” Thorson says.

The huge success of Celeste also “applied pressure on us to deliver something bigger and better with Earthblade, and that pressure is a large part of why working on it has become so exhausting,” Thorson says. “Pedro isn’t to blame for this — in fact the split with him has given us the clarity to see that we have lost our way, and the opportunity to admit defeat.”

Thorson and Berry want to refocus on “smaller-scale projects” and are “prototyping again” to try and “rediscover game development in a manner closer to how we approached it at Celeste’s or TowerFall’s inception.”

You May Also Like

Business

JPMorgan Chase on Wednesday posted record quarterly and annual earnings and revenue, reinforcing the company’s status as the biggest and most profitable bank in U.S....

Editor's Pick

So far this has been a fairly entertaining start to the new year! The S&P 500 started off with a bounce to 6050, pushed...

Editor's Pick

Our strategy at EarningsBeats.com just simply makes good common sense. If you want to find the best earnings reports BEFORE they’re reported, follow relative...

Business

The U.S. Food and Drug Administration formally authorized Zyn nicotine pouches for sale after conducting an ‘extensive scientific review’ about their safety. In a...